Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease

Abstract This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheuma...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2021-01, Vol.72 (1), p.1-8
Main Authors: Lantos, Paul M, Rumbaugh, Jeffrey, Bockenstedt, Linda K, Falck-Ytter, Yngve T, Aguero-Rosenfeld, Maria E, Auwaerter, Paul G, Baldwin, Kelly, Bannuru, Raveendhara R, Belani, Kiran K, Bowie, William R, Branda, John A, Clifford, David B, DiMario, Francis J, Halperin, John J, Krause, Peter J, Lavergne, Valery, Liang, Matthew H, Meissner, H Cody, Nigrovic, Lise E, Nocton, James (Jay) J, Osani, Mikala C, Pruitt, Amy A, Rips, Jane, Rosenfeld, Lynda E, Savoy, Margot L, Sood, Sunil K, Steere, Allen C, Strle, Franc, Sundel, Robert, Tsao, Jean, Vaysbrot, Elizaveta E, Wormser, Gary P, Zemel, Lawrence S
Format: Article
Language:English
Subjects:
Animals
Communicable Diseases
Humans
Lyme Disease - diagnosis
Lyme Disease - drug therapy
Lyme Disease - prevention & control
Neurology
North America
Rheumatology
United States
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR). The scope of this guideline includes prevention of Lyme disease, and the diagnosis and treatment of Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists caring for this condition such as infectious diseases specialists, emergency physicians, internists, pediatricians, family physicians, neurologists, rheumatologists, cardiologists and dermatologists in North America.
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/ciab049